| All patients (n = 400) | Patients with SHR > 0.99 (n = 124) | Patients with SHR ≤ 0.99 (n = 276) | P value |
---|---|---|---|---|
Baseline variables | Â | Â | Â | Â |
Age (years) | 71.0 ± 7.8 | 71.1 ± 8.3 | 70.9 ± 7.6 | 0.896 |
Female, n (%) | 226 (56.5) | 67 (54.0) | 159 (57.6) | 0.505 |
BMI (kg/m2) | 25.2 ± 3.8 | 25.2 ± 4.3 | 25.2 ± 3.6 | 0.989 |
NYHA class III-IV, n (%) | 201 (50.3) | 73 (58.9) | 128 (46.4) | 0.021 |
Systolic BP (mmHg) | 140.9 ± 23.2 | 137.8 ± 24.2 | 142.3 ± 22.6 | 0.074 |
Diastolic BP (mmHg) | 77.9 ± 13.5 | 77.3 ± 14.5 | 78.2 ± 13.0 | 0.538 |
Heart rate | 80.8 ± 17.2 | 83.8 ± 19.6 | 79.5 ± 15.9 | 0.022 |
Comorbidities, n (%) | Â | Â | Â | Â |
CHD | 162 (40.5) | 52 (41.9) | 110 (39.9) | 0.695 |
Atrial fibrillation | 103 (25.8) | 40 (32.3) | 63 (22.8) | 0.046 |
Alcohol | 43 (10.8) | 16 (12.9) | 27 (9.8) | 0.351 |
Smoking | 86 (21.5) | 34 (27.4) | 52 (18.8) | 0.053 |
Hypertension | 298 (74.5) | 86 (69.4) | 212 (76.8) | 0.114 |
Diabetes | 166 (41.5) | 58 (46.8) | 108 (39.1) | 0.151 |
Chronic Kidney Disease | 52 (13.0) | 24 (19.4) | 28 (10.1) | 0.011 |
Hyperlipidemia | 124 (31.0) | 46 (37.1) | 78 (28.3) | 0.077 |
Laboratory data | Â | Â | Â | Â |
HbA1c (g/L) (%) | 6.6 ± 1.3 | 6.7 ± 1.5 | 6.5 ± 1.1 | 0.059 |
ABG (µmol/L) | 6.9 ± 2.7 | 9.4 ± 3.0 | 5.8 ± 1.5 | < 0.001 |
Haemoglobin, g/dL | 126.9 ± 19.1 | 123.0 ± 22.3 | 128.7 ± 17.3 | 0.005 |
TSH (mg/l) | 3.8 ± 9.0 | 4.1 ± 10.4 | 3.8 ± 8.4 | 0.795 |
ALT | 26.5 ± 24.9 | 28.4 ± 20.6 | 25.6 ± 26.6 | 0.297 |
Troponin T | 0.06 ± 0.1 | 0.08 ± 0.1 | 0.05 ± 0.1 | 0.032 |
NT-proBNP (pg/mL) | 1127.0 (573.8-2216.3) | 1476.5 (774.5-2985.5) | 946.0 (485-2010.5) | < 0.001 |
LDL | 2.1 ± 0.8 | 2.1 ± 0.8 | 2.1 ± 0.8 | 0.463 |
Total cholesterol (mmol/L) | 3.9 ± 1.1 | 4.0 ± 1.2 | 3.9 ± 1.1 | 0.386 |
Creatinine (mg/dl) | 90.3 ± 39.6 | 98.7 ± 48.3 | 86.7 ± 34.7 | 0.006 |
eGFR | 70.5 ± 23.5 | 68.9 ± 22.2 | 71.2 ± 24.1 | 0.357 |
Blood urea | 7.6 ± 6.4 | 8.6 ± 5.4 | 7.1 ± 6.7 | 0.036 |
Potassium (mmol/L) | 4.0 ± 0.6 | 3.9 ± 0.7 | 4.0 ± 0.6 | 0.286 |
C-reactive protein | 3.3 (3.0-6.3) | 4.7 (3.1–8.7) | 3.2 (3.0-5.8) | 0.001 |
Medication data | Â | Â | Â | Â |
Beta-blockers | 242 (60.5) | 76 (61.3) | 166 (60.1) | 0.828 |
Diuretics | 192 (48.0) | 70 (56.5) | 122 (44.2) | 0.023 |
MCRA | 129 (32.3) | 45 (36.3) | 84 (30.4) | 0.247 |
Calcium channel blockers | 124 (31.0) | 32 (25.8) | 92 (33.3) | 0.132 |
ACEI + ARB | 197 (49.3) | 58 (46.8) | 139 (50.4) | 0.507 |
Statins | 335 (83.8) | 99 (79.8) | 236 (85.5) | 0.155 |
Echocardiography | Â | Â | Â | Â |
LAVI, mL/m2 | 42.6 ± 6.2 | 43.3 ± 6.4 | 42.3 ± 6.0 | 0.149 |
LVEDD (mm) | 47.4 ± 5.6 | 48.2 ± 5.6 | 47.0 ± 5.6 | 0.038 |
LVESD (mm) | 31.8 ± 6.8 | 33.4 ± 7.9 | 31.1 ± 6.1 | 0.002 |
LVEF (%) | 60.5 ± 5.0 | 59.6 ± 4.6 | 60.9 ± 5.1 | 0.015 |
e’, cm/s | 7.0 (6.0–8.0) | 6.0 (5.0–8.0) | 7.0 (6.0–8.0) | 0.020 |
Septal E/e’ | 15.0 ± 3.0 | 15.6 ± 3.4 | 14.7 ± 2.8 | 0.006 |
PASP | 38.7 ± 11.4 | 39.5 ± 13.3 | 38.3 ± 10.4 | 0.333 |